Drugs Made In America Acquisition II Ord Shs
DMII9.880USD
0.000
交易中 （美东）报价延迟15分钟
--总市值
--市盈率 TTM
关于 Drugs Made In America Acquisition II Ord Shs 公司
Drugs Made In America Acquisition II Corp. is a blank check company. The Company is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar business combination with one or more businesses. The Company intends to search for business combination targets in the pharmaceutical industry. The Company is neither engaged in any operations nor generated any revenues.
Drugs Made In America Acquisition II Ord Shs简介
公司代码DMII
公司名称Drugs Made In America Acquisition II Corp
上市日期Sep 25, 2025
CEOStockwell (Lynn)
员工数量- -
证券类型Ordinary Share
年结日- -
公司地址1 East Broward Boulevard
城市FT LAUDERDALE
上市交易所NASDAQ OMX - NASDAQ BASIC
国家United States of America
邮编33301
电话19548703099
网址
公司代码DMII
上市日期Sep 25, 2025
CEOStockwell (Lynn)
Drugs Made In America Acquisition II Ord Shs公司高管
名称
名称/职务
职务
持股
持股变动
Mr. Saleem Elmasri, CPA
Mr. Saleem Elmasri, CPA
Chief Financial Officer, Principal Financial and Accounting Officer
Chief Financial Officer, Principal Financial and Accounting Officer
--
--
Mr. Glenn Worman
Mr. Glenn Worman
Chief Financial Officer, Principal Financial and Accounting Officer
Chief Financial Officer, Principal Financial and Accounting Officer
--
--
Dr. Catherine Do
Dr. Catherine Do
Independent Director
Independent Director
--
--
Dr. G. Sridhar Prasad
Dr. G. Sridhar Prasad
Independent Director
Independent Director
--
--
Mr. Myron W. Shulgan
Mr. Myron W. Shulgan
Independent Director
Independent Director
--
--
Ms. Lynn Stockwell
Ms. Lynn Stockwell
Executive Chairman of the Board, Chief Executive Officer
Executive Chairman of the Board, Chief Executive Officer
--
--
名称
名称/职务
职务
持股
持股变动
Mr. Saleem Elmasri, CPA
Mr. Saleem Elmasri, CPA
Chief Financial Officer, Principal Financial and Accounting Officer
Chief Financial Officer, Principal Financial and Accounting Officer
--
--
Mr. Glenn Worman
Mr. Glenn Worman
Chief Financial Officer, Principal Financial and Accounting Officer
Chief Financial Officer, Principal Financial and Accounting Officer
--
--
Dr. Catherine Do
Dr. Catherine Do
Independent Director
Independent Director
--
--
Dr. G. Sridhar Prasad
Dr. G. Sridhar Prasad
Independent Director
Independent Director
--
--
Mr. Myron W. Shulgan
Mr. Myron W. Shulgan
Independent Director
Independent Director
--
--
Ms. Lynn Stockwell
Ms. Lynn Stockwell
Executive Chairman of the Board, Chief Executive Officer
Executive Chairman of the Board, Chief Executive Officer
--
--
收入明细
由于公司未披露，未能获取相关数据
由于公司未披露，未能获取相关数据
业务
地区
由于公司未披露，未能获取相关数据
股东统计
持股股东
股东类型
持股股东
持股股东
占比
其他
100.00%
持股股东
持股股东
占比
其他
100.00%
股东类型
持股股东
占比
其他
100.00%
机构持股
由于公司未披露，未能获取相关数据
报告期
机构数
持股数
持股占比
持股变动
暂无数据
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
暂无数据
持股ETF
机构名称
占比
暂无数据
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据
常见问题
Drugs Made In America Acquisition II Ord Shs的前五大股东是谁？
Drugs Made In America Acquisition II Ord Shs 的前五大股东如下：
Drugs Made In America Acquisition II Ord Shs的前三大股东类型是什么？
Drugs Made In America Acquisition II Ord Shs 的前三大股东类型分别是：
其他
其他
有多少机构持有Drugs Made In America Acquisition II Ord Shs(DMII)的股份？
截至--，共有--家机构持有Drugs Made In America Acquisition II Ord Shs的股份，合计持有的股份价值约为--，占公司总股份的--%。与--相比，机构持股有所增加，增幅为--。
哪个业务部门对Drugs Made In America Acquisition II Ord Shs的收入贡献最大？
在--，--业务部门对Drugs Made In America Acquisition II Ord Shs的收入贡献最大，创收--，占总收入的--%。
